AUBURN KIDD: Open Payments
NPI 1780141200 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,399 in 88 payments from 14 companies in 2025. Trend: 2023 $1,472 · 2024 $1,532 · 2025 $1,399
Food & beverage: $1,299Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $247 |
| Galderma Laboratories, L.P. | 17 | $199 |
| UCB, Inc. | 21 | $182 |
| GENZYME CORPORATION | 8 | $150 |
| Janssen Biotech, Inc. | 3 | $149 |
| Novartis Pharmaceuticals Corporation | 5 | $124 |
| Lilly USA, LLC | 4 | $79 |
| Incyte Corporation | 3 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| Amgen Inc. | 2 | $46 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, SKYRIZI, TREMFYA, COSENTYX, RINVOQ, TALTZ.
Industry payments across MS — which companies pay providers there.
